P1 VARIANT ANTITHROMBINS GLASGOW (393 ARG TO HIS) AND PESCARA (393 ARG TO PRO) HAVE INCREASED HEPARIN AFFINITY AND ARE RESISTANT TO CATALYTIC CLEAVAGE BY ELASTASE - IMPLICATIONS FOR THE HEPARIN ACTIVATION MECHANISM

被引:21
作者
OWEN, MC [1 ]
GEORGE, PM [1 ]
LANE, DA [1 ]
BOSWELL, DR [1 ]
机构
[1] CHARING CROSS & WESTMINSTER MED SCH,DEPT HAEMATOL,LONDON,ENGLAND
关键词
ANTITHROMBIN; HEPARIN BINDING; REACTIVE SITE MUTANT;
D O I
10.1016/0014-5793(91)80296-F
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The heparin affinity of normal and two P1 variants of antithrombin-III (AT) was studied by gradient elution with NaCl in Tris buffer on heparin-Sepharose. At pH 7.4 normal AT eluted at [Na+] 0.78 mol/l and the variants both showed increased affinity with AT Pescara eluting at [Na+] 0.86 mol/l and AT Glasgow at [Na+] 0.92 mol/l. We have earlier proposed a model for heparin activation in which the native state of AT maintains a salt bridge involving the P1 Arg-393 residue. Binding of heparin induces a higher heparin affinity conformation in which the salt bridge is disrupted to reveal the reactive centre for inhibition of thrombin. The Glasgow and Pescara variants, lacking a reactive centre P1 basic residue, would be unable to form this salt bridge, and we suggested that the high affinity conformation which they adopt as their native state would resemble the heparin induced conformation. To examine this model, we measured the heparin induced fluorescence of two P1 variants and tested the susceptibility of their reactive loops to catalytic cleavage. Both variants had fluorescence spectra indistinguishable from normal AT. In the absence of heparin, neither variant was more susceptible than normal to catalytic cleavage by human neutrophil elastase. These findings suggest that the conformation of these P1 variants is different to that of fully heparinized normal AT.
引用
收藏
页码:216 / 220
页数:5
相关论文
共 14 条
  • [1] PROPOSED HEPARIN BINDING-SITE IN ANTITHROMBIN BASED ON ARGININE-47 - A NEW VARIANT ROUEN-II, 47-ARG TO SER
    BORG, JY
    OWEN, MC
    SORIA, C
    SORIA, J
    CAEN, J
    CARRELL, RW
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (04) : 1292 - 1296
  • [2] Carrell R. W., 1987, THROMB DIATH HAEMO, P1
  • [3] PLAKALBUMIN, ALPHA-1-ANTITRYPSIN, ANTITHROMBIN AND THE MECHANISM OF INFLAMMATORY THROMBOSIS
    CARRELL, RW
    OWEN, MC
    [J]. NATURE, 1985, 317 (6039) : 730 - 732
  • [4] CARRELL RW, 1989, MOL BIOL MED, V6, P35
  • [5] CHANG JY, 1989, J BIOL CHEM, V264, P3111
  • [6] ERDJUMENT H, 1988, J BIOL CHEM, V263, P5589
  • [7] LAEMMLI UK, 1970, NATURE, V227, P685
  • [8] ANTITHROMBIN-III NORTHWICK-PARK - DEMONSTRATION OF AN INACTIVE HIGH MW COMPLEX WITH INCREASED AFFINITY FOR HEPARIN
    LANE, DA
    FLYNN, A
    IRELAND, H
    ERDJUMENT, H
    SAMSON, D
    HOWARTH, D
    THOMPSON, E
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1987, 65 (04) : 451 - 456
  • [9] LANE DA, 1989, J BIOL CHEM, V264, P10200
  • [10] ELECTROIMMUNO ASSAY
    LAURELL, CB
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1972, 29 : 21 - &